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Silencing( Beta2-Adrenergic( Receptors( Reduces( Intraocular(
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The( search( for( new( treatments( for(ocular(hypertension(and(glaucoma,(due( to( the(
side(effects(commercial(products(present,(is(inviting(to(look(for(new(strategies(apart(
from(the(available(ones.( In(this(sense(the( interference(RNA(technique((RNAi),(also(
known( as( siRNA( to( selectively( silence( beta2( adrenergic( receptors( has( been(
investigated.( In(this(sense(it(has(been(obtained(a(reduction(in( intraocular(pressure(
(IOP),( the( main( factor( triggering( glaucoma,( of( 30( ±( 5( %,( compared( to( a( control(








Los$ Receptores$ con$ Silenciador$ Beta23Adrenérgicos,$ reducen$ la$ presión$
intraocular:$Un$nuevo$acercamiento$a$la$terapia$del$Glaucoma$
La( búsqueda( de( nuevos( tratamientos( para( la( hipertensión( ocular( y( el( glaucoma,(
dado( los( efectos( secundarios( que( presentan( los( fármacos( actuales,( sugieren( el(
desarrollo(de(estrategias(diferentes(a( las(actualmente(disponibles.(En(este(sentido(






factor( desencadenante( del( glaucoma.( El( empleo( de( un( siRNA(de( origen( comercial(
para(el(receptor(beta2(ha(producido(una(reducción(sustancial(de(la(PIO(de(30(±(5(%,(
comparado(con(el(control,(un(siRNA(sin(sentido((scramble).(Estos(resultados(fueron(
en(magnitud( semejantes(al( de( los( fármacos( comerciales( salvo(que( la(duración(del(
siRNA(para(el(receptor(beta2(adrenérgico(duró(casi(5(días(en(comparación(de(las(8(
horas(que(suelen(durar( los( fármacos(comerciales.( Los(estudios(en( relación(con( los(
efectos(secundarios(no(mostraron(ninguna(modificación(en(las(estructuras(oculares.(
En( resumen,( el( empleo( de( los( siRNA( frente( a( los( receptores( beta2( adrenérgicos(
presenta( muy( buenas( perspectivas( como( aproximación( novedosa( para( el(
tratamiento(del(glaucoma.((
Palabras.clave:!Glaucoma;!Presión!intraocular;!Receptores!adrenérgicos;!siRNA.!
1.(INTRODUCTION(The! aqueous! humour! is! a! transparent! nutritional! fluid! that! provides! the!nutrients!to!the! inner!avascular!structures!of! the!eye!(1).!This! fluid!also!gives!an!internal!pressure,!termed!intraocular!pressure!or!IOP!that!grants!the!right!shape!of!the!ocular!globe.!The!maintenance!of!an!adequate!balance!between!the!formation!and!the!drainage!of!the!aqueous!humour!is!a!guarantee!of!ocular!health!(2).!When!changes! in! the! aqueous!humour!dynamics!occur! concomitant! alterations!happen!that!may!lead!in!pathological!states.!One!problem!derived!from!the!accumulation!of! the! aqueous! humour! in! the! eye! is! the! degeneration! of! the! optic! nerve! as! a!consequence! of! the! increase! in! the! intraocular! pressure! (3).! This!pathophysiological!condition!is!generally!termed!as!glaucoma!and!is!in!most!of!the!cases! due! to! problems! in! the! drainage! of! the! aqueous! humour! rather! than! a!problem!in!its!synthesis.!!The! control! of! the! aqueous! humour!production! occurs! in! the! ciliary! body!and!it!is!regulated!by!the!sympathetic!nervous!system!(4).!Noradrenaline!released!from! the! sympathetic! terminals! stimulate!adrenergic! receptors! that! facilitate! the!production!of!the!aqueous!humour.!This!fact!has!been!taken!by!the!pharmaceutical!companies!to!develop!a!series!of!antagonists!of!mainly!β2Yadrenoceptors!although!
α1!agonists!seem!to!help!to!reduce!aqueous!humour!synthesis!(4).!Recently,! a!new!biochemical! approach! to!avoid! the!expression!of!proteins!has! been! discovered:! ! Small! interference! RNA.! These! are! double! stranded! RNA!sequences!that!after!being!processed!in!the!cytoplasm!they!destroy!the!mRNA!to!which! it! has! been! designed! avoiding! the! synthesis! of! the! corresponding! protein!(5).!
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In!the!present!work,!the!use!of!siRNA,!designed!to!silence!β2Yadrenoceptors!has! been! used! in! order! to! reduce! IOP! and! therefore! consider! it! as! a! possible!strategy!for!the!treatment!of!ocular!hypertension!and!glaucoma.!
2.(MATERIAL(AND(METHODS(
2.1.$Animals$Male! New! Zealand! rabbits! were! 6Y8! weeks! of! age! at! the! time! of! the!experiment.! The! siRNAs! were! topically! applied! in! one! eye,! the! contralateral!receiving!the!same!volume!of!saline.!Each!of!the!treated!eyes!received!an!amount!of! 250! µg! of! the! siRNA! dissolved! in! 40! µL! of! 0.9! %! NaCl.! The! instillation! was!performed!in!a!blind!fashion!therefore!no!indication!of!the!saline.!The!siRNA!were!applied! in! a! blind! fashion! Rabbit! eyes! were! treated! with! 1,1! mg! HPLCYpurified!siRNAs,!applied.!The!siRNAs!were!applied! in!one!single!eye! in!265!µg!0.9%!NaCl!drops!(40!µL!volume)!on!four!consecutive!days;!the!contralateral!eye!was!instilled!with!saline!solution!(0.9%!NaCl).!Experiments!were!performed!using!a!single!blind!design:! no! visible! indication! was! given! to! the! experimenter! as! to! the! applied!solution! (agent! or! vehicle).! IOP! was! measured! on! ten! days! and,! afterwards,!animals!were!killed!and!both!eyes!were!collected.!
2.2.$Intraocular$pressure$(IOP)$measurements$in$rabbits$IOP!was!measured!by!means!of!a!TonoYPen!XL!contact!tonometer!(Mentor!Massachusetts!Inc.,!Norwell,!MA).!Topical!anesthesia!(Colircusi,!Laboratorios!Cusi,!Spain:!0.1!mg/ml!tetracaine!plus!0.4!mg/ml!oxybuprocaine!in!0.9%!saline,!diluted!1:3!in!0.9%!saline)!was!applied!(10!μL)!to!the!cornea!before!each!measurement!to!avoid!animal!discomfort.!All!the!siRNA!experiments!were!performed!and!measured!at!the!same!time.!In!each!series!of!experiments,!IOP!was!measured,!from!the!first!day,!three!times!a!day!every!four!hours!and,!once!the!IOP!started!to!change!the!measurement!pattern!moved!once!every!two!hours.!The!siRNA!assays!carried!out!were!purchased!from!Santa!Cruz!(USA)!(n=8),!and!siRNA!scramble!was!also!from!Santa!Cruz!(USA)(n=4).!In!the!experiments!performed!with!commercially!available!drugs!(40!µL!of!commercial!Xalatan,!Trusopt!and!Timoftol),!IOP!levels!were!measured!every!hour!for!a!total!of!8!hours,!following!the!same!protocol!as!described!before.!!
2.3.$Cell$treatments$and$tissue$sections$and$histology$Ciliary! body! nonYpigmented! epithelial! cells!were! used! in! order! to! see! the!silencing!of! the!beta2! adrenergic! receptors.!These! cells!were!kindly!provided!by!Dr.! CocaYPrados! (University! of! Yale),! and!were! treated!with! an! antibody! against!the!beta2!adrenergic!receptor!(Ab40834!from!abcam).!!
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After! several!washes! in! PBS! and! preYincubation! in! PBS!with! 3%!blocking!serum! for! 1! h,! cells!were! incubated!with! the! primary! goat! polyclonal! antiYbeta2!(Ab40834! from! abcam)! diluted! 1:100.! After! this! incubation,! cells! were! washed!with!PBS! and! incubated! in! a!dark! chamber!with! the! secondary! antibody!donkey!antiYgoat! IgGYFITC!at!1:150!(Jackson! ImmunoResearch,!PA,!USA)! for!1!h! to!37ºC.!Then,!the!samples!were!observed!under!a!confocal!microscope!(Axiovert!200;!Carl!Zeiss!Meditec! GmbH,! Jena,! Germany),! equipped!with! a! PASCAL! confocal!module!(LSM!5;!Zeiss).!All!images!were!managed!with!the!accompanying!PASCAL!software.!Eyes!were!fixed!in!4%!paraformaldehyde!in!PBS!1X!overnight!at!4ºC.!Eyes!were!washed!twice!in!PBS!1X!for!15!min,!and!immersed!in!11%!sucrose!overnight!at!4ºC.!The!following!day!the!eyes!were!immersed!in!33%!sucrose!prepared!in!PBS!1X.!Finally,!the!eyes!were!embedded!in!OCT!(Leica).!5Y10!µm!sections!were!made!using!a!LEICA!CM!1850!cryotome,!in!3Yaminopropiltrietoxisilane!coated!glasses.!HaematoxylinYeosin! staining!was! performed! using! the! following! protocol:!Sections!were! fixed!and!washed! in!water! for!5!minutes.!Haematoxylin! (Carazzi´s!Heamtoxylin,!Panreac,!Barcelona,!Spain)!was!incubated!for!1!minute!and!sections!were!washed!in!water!for!10!minutes.!Eosin!(Eosin!Bluish,!Panreac)!contrast!was!made!and!finally!sections!were!washed!serially!with!96º!and!100º!ethanol.!Finally,!xilol! treatment! was! performed! to! dehydrate! the! sections! previous! to! their!observation!by!means!of!the!microscope.!Microscopy!was!performed!with!a!confocal!Zeiss!Axiovert!200M!microscope!(Zeiss,!Jena,!Germany),!equipped!with!a!LSM!5!Pascal!confocal!module.!All!images!were!managed!with!the!LSM!5!Pascal!software.!
2.4.$Side$effects$The! assessment! of! the! ocular! tolerance! of! the! RNAi! sequences,! were!followed! several! aspects! and! parameters! from! the! tear! film,! ocular! anexa! and!ocular! surface.! The! analysis! were! performed! and! graded! before! and! after! the!topical! application! of! siRNA! with! the! Efron! grading! scales.! A! Topcon! SLY8Z! slit!lamp!and!a!Topcon!SPY2000P!specular!microscope!(Topcon!Spain,!Madrid,!Spain),!as!well!as!a!digital!camera!and!a!“de!visu”!exam,!were!used!for!every!experiment.!SlitYlamp! images! were! captured! under! 10X! augments,! a! diffuser! filter! and! a!medium! degree! of! illumination.! The! images! were! recorded! and! analysed! by!IMAGEnet!2000!system!software!(Topcon).!




3.1.$Effect$of$beta2$adrenergic$receptor$silencing$To! see! whether! the! silencing! of! beta2! adrenergic! receptors! produced!changes!in!the!IOP,!the!rabbits!treated!with!the!siRNA!against!the!beta2!receptor!were!monitored!in!their!IOP!for!7!days.!As!presented!in!figure!1,!there!was!a!robust!reduction!in!IOP!which!started!to!be!measurable!24!hours!after!the!instillation!of!the!siRNA!and!which!was!statistically!significant!for!5!days.!The!maximal!reduction!obtained! after! silencing! the! beta2! receptor! was! 30! ±! 5! %! compared! to! control!(n=6).! This! and! similar! values! were! maintained! for! 1Y2! days,! with! the! IOP!remaining! low!for!three!more!days!(with!a!mean!of!30!%!of!reduction)!and!then!returning!slowly!towards!control!values!(Figure!1).!!!
.




3.2.$Demonstration$of$the$beta2$receptor$silencing$When! comparing! the! fluorescence! level! of! nonYtreated! cells! with! those!treated!with! the! siRNA! designed! for! the! beta2! adrenergic! receptor,! it! was! clear!that!the!siRNA!was!able!to!significantly!reduce!the!amount!of!receptors!according!to! the! clear! fading! of! the! fluorescence! present! in! treated! cells.! As! observed! in!Figure! 2,! there! was! a! reduction! in! the! presence! of! the! beta2! receptors! in! the!treated! ciliary! nonYpigmented! epithelial! cells!which! reduction!was! 66.5!±! 7.2!%!with!respect!to!control!(100!%;!n=4).!!!!!!!!!!!!!!!!!!!
Figure.2.7!Beta2!adrenergic!immunostaining!of!ciliary!nonYpigmented!epithelial!cells!before!(upper!panels)!and!after!!the!treatment!of!the!siRNA!(lower!panels).!The!receptor!can!be!observed!in!green!on!the!left!panels!while!Nomarsky!Interferencial!Contrast!can!observe!the!same!cells!on!the!right.!!





been! assayed.! A! single! drop! (40! µL)! has! been! instilled! in! rabbit! eyes! and! IOP!measures!have!been!performed!each!hour!for!8!hours.!!!!
!
Figure. 3.7! Comparative! effects! of! commercial! compounds! currently! used! for! the! treatment! of!glaucoma!as!well!as!the!siRNA!used!along!this!research.!(***p<0.001).!! As!described!in!Figure!3,!any!of!those!compounds!produced!a!reduction!in!IOP!of!between!20Y35%!and!the!duration!of! this!effect!was!about!6!hours.!These!experiments!confirmed!the!suitability!of! this!animal!model,!due! to! its!ability!and!flexibility!to!regulate!the!IOP,!to!be!used!with!RNAi!applications.!!
3.4.$Side$effects$The! integrity! of! the! ocular! structures! after! the! siRNAs! application! was!assessed! observing! the! ciliary! processes! under! microscopy! by! means! of!haematoxylinYeosin! staining! (Figure! 4).! No! differences! were! observed! between!treated!and!nonYtreated!animals.!!




Figure. 4.7.Lack!of! changes! in! the!ocular!anatomy!after! the! treatment!with! the!siRNA!against! the!beta2! adrenergic! receptor.! a)! Control! eye! of! an! untreated! animal! showing! the! main! parts! of!anterior! and! posterior! chamber.! b)! siRNA! treated! eye! obtained! after! completing! the! whole!experimental!time.!CO:!cornea,!IR:!iris,!CB:!ciliary!body,!L:!lens.!!









some! benefit! with! respect! to! other! pathologies! or! strategies.! In! contrast,! RNAi!systemic!delivery!requires!larger!amounts!of!product!and!favours!a!broad!delivery,!sometimes!affecting,!nonYspecific!tissues!such!as!liver,!lung!and!spleen.!!In!this!way,!one!important!point!to!be!considered!is!to!verify!that!the!topical!application! of! the! siRNA! effectively! passes! through! the! cornea! to! reach! the!targeted!tissues.!The!eGFP!mouse!has!been!a!useful!model!to!validate!the!delivery!of! these! oligonucleotides! to! the! ciliary! body.! The! siRNA! silencing! GFP! are!efficiently! taken! up! by! ocular! tissues,! reaching! the! ciliary! body! and! other!structures,! and!effectively! silenced!endogenous!eGFP!expression! for!at! least! four!days,!when!consecutive!administrations!were!applied.!SiRNAs!have!been!topically!administered! and! it! is! presumed! that! it! can! be! delivered! by! either! transcellular!transport!across!the!corneal!epithelium!and!stroma!(9)!or!by!the!paracellular!way!(10).! The! corneal! epithelium! seems! to! be! the! barrier,! which! limits! transcorneal!diffusion! although! the! existence! of! the! paracellular! way!would! be! a!mechanism!that! allows! the! transport! of! siRNA! inside! the! eye.! The! spaces! between! cells,!estimated! to! be! about! 60! Å,! permit! molecules! to! gain! access! to! the! anterior!chamber! (10).! It! is! difficult! to! evaluate! quantitatively! how!much! of! the! applied!siRNA!reaches!the!ciliary!processes,!nevertheless!and!by!means!of!the!experiments!performed!with! the!eGFP!mouse! it!has!been!possible! to!demonstrate! that! siRNA!penetrates! and! that! they! can! diminish! the! fluorescence! of! intracellular! ocular!structures.!Therefore,!these!experiments!allowed!us!to!confirm!a!positive!delivery!in!several!ocular!structures!and!to!establish!the!proper!protocol!for!each!of!them.!!Once! the! in! vivo! ocular! approach! of! RNAi! technology! was! tried! out,! our!main!aim!was!to!confirm!this!strategy!as!a!new!open!angle!glaucoma!treatment.!To!this! end,! we! focused! our! attention! on! beta2! adrenergic! receptors,! since! their!commercial! inhibitors! are! effective! in! lowering! IOP,! the! primary! indication! of!glaucoma!(11).!These!receptors!are!mainly!located!in!the!trabecular!meshwork!in!the!ciliary!body.!!The!principal!finding!of!this!paper!is!the!development!of!therapeutic!siRNAs!targeting! the! beta2! adrenergic! receptors,! which! are! involved! in! intraocular!pressure.!The!use!of!siRNA!may!offer!advantages!and!may!be!preferable!to!DNAYbased! strategies! for! in! vivo! applications,! although! the! instability! and! the! poor!uptake! into! target! tissues! remain! the! most! important! handicaps.! A! commercial!sequence!was!tested!in!vivo!in!rabbits!with!very!interesting!results.!!According! to! the! in! vivo!data!obtained! in! the! eGFP!mouse!model,! optimal!delivery!time,!application!pattern!and!effective!RNAi!sequence!dose!was!estimated!for! the! normotensive! New! Zealand! white! rabbit! model.! For! these! experiments,!targeting! the! ciliary! body,! 0.265! mg! of! beta2! adrenergic! receptor! siRNA! were!administered!daily!in!a!single!dose!on!four!consecutive!days.!The!results!confirmed!the!reduction!of!the!IOP!in!rabbits,!in!a!marked!and!sustained!way.!!
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